Clinical

Dataset Information

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors


ABSTRACT: 24 participants are expected to be enrolled for this open,Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with relapsed/refractory advanced solid tumors.

DISEASE(S): Lung Cancer,Sarcoma,Carcinoma, Bronchogenic,Small Cell Lung Cancer,Colorectal Cancer,Small Cell Lung Carcinoma,Non Small Cell Lung Cancer,Liver Cancer,Pancreatic Cancer,Breast Cancer,Lung Neoplasms,Ovarian Cancer,Bronchial Cancer,Gastric Cancer,Head And Neck Cancer

PROVIDER: 62093 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR